{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:43:47Z","timestamp":1778661827825,"version":"3.51.4"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T00:00:00Z","timestamp":1281657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,1]]},"abstract":"<jats:p>The first case of biopsy-proven lenalidomide-induced acute interstitial nephritis is presented.<\/jats:p>","DOI":"10.1634\/theoncologist.2010-0070","type":"journal-article","created":{"date-parts":[[2010,8,14]],"date-time":"2010-08-14T02:11:39Z","timestamp":1281751899000},"page":"961-964","source":"Crossref","is-referenced-by-count":24,"title":["Lenalidomide-Induced Acute Interstitial Nephritis"],"prefix":"10.1093","volume":"15","author":[{"given":"Evan J.","family":"Lipson","sequence":"first","affiliation":[{"name":"a Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol Ann","family":"Huff","sequence":"additional","affiliation":[{"name":"a Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danniele G.","family":"Holanda","sequence":"additional","affiliation":[{"name":"b Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"McDevitt","sequence":"additional","affiliation":[{"name":"a Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek M.","family":"Fine","sequence":"additional","affiliation":[{"name":"c Department of Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,8,13]]},"reference":[{"key":"2021122207520070800_R1","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1080\/10428190802023707","article-title":"Azotemia associated with use of lenalidomide in plasma cell dyscrasias","volume":"49","author":"Batts","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"2021122207520070800_R2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1523-1755.2003.00071.x","article-title":"Toxic acute tubular necrosis following treatment with zoledronate (Zometa)","volume":"64","author":"Markowitz","year":"2003","journal-title":"Kidney Int"},{"key":"2021122207520070800_R3","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM200310233491721","article-title":"Renal failure with the use of zoledronic acid","volume":"349","author":"Chang","year":"2003","journal-title":"N Engl J Med"},{"key":"2021122207520070800_R4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1634\/theoncologist.10-10-842","article-title":"Renal safety and efficacy of i.v. bisphosphonates in patients with skeletal metastases treated for up to 10 years","volume":"10","author":"Guarneri","year":"2005","journal-title":"The Oncologist"},{"key":"2021122207520070800_R5","first-page":"144","article-title":"[\u201cOccult\u201d renal insufficiency due to evaluating renal function using only serum creatinine.]","volume":"22","author":"Fern\u00e1ndez-Fresnedo","year":"2002","journal-title":"Nefrologia"},{"key":"2021122207520070800_R6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-93-5-735","article-title":"Acute interstitial nephritis due to drugs: Review of the literature with a report of nine cases","volume":"93","author":"Linton","year":"1980","journal-title":"Ann Intern Med"},{"key":"2021122207520070800_R7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1517\/13543784.15.7.805","article-title":"Immunomodulatory drugs in myelodysplastic syndromes","volume":"15","author":"Galili","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"2021122207520070800_R8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00262-008-0620-4","article-title":"The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells","volume":"58","author":"Galustian","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"2021122207520070800_R9","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood-2005-10-4184","article-title":"Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: Therapeutic implications","volume":"108","author":"Chang","year":"2006","journal-title":"Blood"},{"key":"2021122207520070800_R10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1756-8722-2-36","article-title":"Mechanism of action of lenalidomide in hematological malignancies","volume":"2","author":"Kotla","year":"2009","journal-title":"J Hematol Oncol"},{"key":"2021122207520070800_R11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","article-title":"Drug-induced acute interstitial nephritis","volume":"60","author":"Rossert","year":"2001","journal-title":"Kidney Int"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2010-0070","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2010-0070","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/15\/9\/961\/41843812\/oncolo_15_9_961.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/15\/9\/961\/41843812\/oncolo_15_9_961.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T11:11:27Z","timestamp":1640171487000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/15\/9\/961\/6399495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,13]]},"references-count":11,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2010,8,13]]},"published-print":{"date-parts":[[2010,9,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2010-0070","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,9,1]]},"published":{"date-parts":[[2010,8,13]]}}}